Chronic Low Grade Inflammation in Pathogenesis of PCOS
Open accessThe DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant clinical implications and can lead to health problems related to the accumulation of adipose tissue, such as obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. There is also evidence that PCOS patients are at higher risk of cardiovascular diseases, atherosclerosis, and high blood pressure. Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation. According to known data, inflammatory markers or their gene markers are higher in PCOS patients. Correlations have been found between increased levels of C-reactive protein (CRP), interleukin 18 (IL-18), tumor necrosis factor (TNF-α), interleukin 6 (IL-6), white blood cell count (WBC), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) in the PCOS women compared with age- and BMI-matched controls. Women with PCOS present also elevated levels of AGEs and increased RAGE (receptor for advanced glycation end products) expression. This chronic inflammatory state is aggravating by obesity and hyperinsulinemia. There are studies describing mutual impact of hyperinsulinemia and obesity, hyperandrogenism, and inflammatory state. Endothelial cell dysfunction may be also triggered by inflammatory cytokines. Many factors involved in oxidative stress, inflammation, and thrombosis were proposed as cardiovascular risk markers showing the endothelial cell damage in PCOS. Those markers include asymmetric dimethylarginine (ADMA), C-reactive protein (CRP), homocysteine, plasminogen activator inhibitor-I (PAI-I), PAI-I activity, vascular endothelial growth factor (VEGF) etc. It was also proposed that the uterine hyperinflammatory state in polycystic ovary syndrome may be responsible for significant pregnancy complications ranging from miscarriage to placental insufficiency. In this review, we discuss the most importance evidence concerning the role of the process of chronic inflammation in pathogenesis of PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“COCs also exacerbate the inflammatory state present in these patients, which is likely related to increased aldosterone–renin ratio and CRP [12,14].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“The release of inflammatory markers is associated with long-term metabolic complications and high cardiovascular risk [12].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Compared with control women, patients with PCOS presented higher circulating concentrations of markers such as homocysteine, asymmetric dimethylarginine, and increased superoxide dismutase activity and decreased glutathione levels and paraoxonase-1 activity [2].”
BackgroundMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186 · cited 1×
“Obesity is a metabolic condition characterized by chronic inflammation state with higher pro-inflammatory cytokines, chemokines, and oxidative stress (OS) markers levels [5,6].”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Metabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Cited by
Items 201–300 of 731
The therapeutic effect of anti-CD19 antibody on DHEA-induced PCOS mice
Wang, T., Xiong, X., Xiao, N., Yan, Y., Liu, X., Xie, Q., Su, X. W., Chen, M., Peng, J., Wang, S., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111711 · Cited by 13
Wang, J., Zhou, W., Song, Z., Ni, T., Zhang, Q., Chen, Z., & Yan, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac726 · Cited by 12
Identification of MAP1LC3A as a promising mitophagy-related gene in polycystic ovary syndrome
Yang, Y., Chen, X., Liao, X., Jiang, W., Zhou, Y., Sun, Y., & Zheng, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-67969-9 · Cited by 11
Wang, M., Huang, J., Shi, Y., Mprah, R., Ding, H., Zhang, S., & Li, C. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108089 · Cited by 10
Ding, J., Mei, S., Mengcheng, C., Zhang, D., & Jin, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2635375 · Cited by 11
Jangam, A., Kotipalli, R. S. S., Patnaik, S. S., Kasireddy, B., Gaja, S. K., Sreedhar, B., Jerald, M. K., Addlagatta, A., & Muralidharan, K. (2023) · Phytomedicine Plus · doi:10.1016/j.phyplu.2023.100515 · Cited by 10
Garcia, C., Vélez, L. M., Ujagar, N. S., Mundo, Z. D. D., Nguyen, T., Fox, C. W., Mark, A., Fisch, K. M., Lawson, M. A., Dulęba, A. J., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1279878 · Cited by 10
Zhao, Y., Pang, J., Fang, X., Yan, Z., Yang, H., Deng, Q., Ma, T., Lv, M., Li, Y., Tu, Z., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1348368 · Cited by 13
Veličković, N. A., Mićić, B., Teofilović, A., Milovanovic, M., Jovanović, M., Djordjevic, A. D., Μacut, D., & Milutinović, D. V. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1402905 · Cited by 11
Yuan, Y., Mao, Y., Yang, L., Wang, Y., & Zhang, X. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1417983 · Cited by 15
When IGF-1 Meets Metabolic Inflammation and Polycystic Ovary Syndrome
Li, X., Lin, S., Yang, X., Chen, C., Cao, S., Zhang, Q., Ma, J., Zhu, G., Zhang, Q., Fang, Q., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112529 · Cited by 10
Polycystic Ovary Syndrome, Endometriosis, and Venous Thromboembolism: A Population-Based Study
Kigloo, H. N., Mai, V., Suarthana, E., Tulandi, T., & Provencher, S. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000545518 · Cited by 9
Qi, S., Yu, H., Hu, W., Xia, D., Shi, Q., & Wang, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-15026-4 · Cited by 13
Hippo signaling pathway in polycystic ovary syndrome
Wen, J., Cheng, G., Zhang, Y., & Liu, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1623143 · Cited by 10
Aditya, R., Santoso, B., & Widjiati, W. (2022) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres22.1408_10.4.725 · Cited by 9
Uluğ, E., & Açıkgöz, A. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00488-7 · Cited by 10
Salcedo, A. C., Yun, J., Carter, C. S., & Hart, E. A. (2023) · Nutrients · doi:10.3390/nu15173760 · Cited by 11
Yang, X., Liu, P., He, H., Qi, D., & Yan, L. (2024) · Molecular Human Reproduction · doi:10.1093/molehr/gaae005 · Cited by 10
YKL-40 Knockdown Decreases Oxidative Stress Damage in Ovarian Granulosa Cells
Tang, T., Gao, J.-Y., Pan, X., Tang, Q., Long, H., & Liu, Z. (2024) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2023.0361 · Cited by 9
Kong, F., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C., Jin, Y., Ma, Y., & Chen, J. (2024) · BMC Medicine · doi:10.1186/s12916-024-03434-8 · Cited by 9
Yang, X., Xiaoping, W., Nan, D., Zhang, J., Li, X., Yuan, L., Zhao, M., & Wang, F. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2173948 · Cited by 9
Kallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study
Yurtkal, A., & Canday, M. (2024) · Diagnostics · doi:10.3390/diagnostics14141553 · Cited by 9
Sobczuk, J., Paczkowska, K., Andrusiów, S., Bolanowski, M., & Daroszewski, J. (2024) · Biomolecules · doi:10.3390/biom14080918 · Cited by 10
Role of IL-6 in Physiology and Pathology of the Ovary
Tan, B., & Wang, J. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5109208 · Cited by 8
Isatin ameliorates ovarian inflammation and apoptosis caused by hormonal imbalances in PCOS mice
Li, X., Ye, T., Zhu, W., Gu, J., Zheng, Z., Wang, C., Zhang, X., Geng, H., Zhou, W., Tan, X., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117083 · Cited by 9
Chen, M., Meng, J., Jin, Y., Chen, Y., Liu, Y., Yuan, X., Qin, Z., & Cao, X. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01788-y · Cited by 8
Bucheeri, S., Alcibahy, Y., Bucheeri, Y., Bucheeri, S., Alhermi, A., & Butler, A. E. (2025) · Cells · doi:10.3390/cells14221769 · Cited by 8
Li, X., Liao, M., Shao, J., Li, W., Shi, L., Wang, D., Juan, N., Shen, Q., Yang, F., Peng, G., et al. (2022) · Mediators of Inflammation · doi:10.1155/2022/9620423 · Cited by 8
Jiao, Y.-Y., Song, N., Fang, X.-Y., Lu, X., Sun, N., Jin, H.-X., Chen, L., Huang, X., Wen, S., Wu, Z., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112292 · Cited by 8
Impact of repeated ovarian hyperstimulation on the reproductive function
Sampaio, O. G. M., Santos, S. A. A. R., Damasceno, M. D. B. M. V., Joventino, L. B., Schneider, A., Masternak, M. M., Campos, A. R., & Cavalcante, M. B. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104277 · Cited by 8
Low-Calorie Sweeteners and Reproductive Health: Evidence and Debates
Atalay, E. Ç., Demirhan, B. E., & Celep, G. S. (2024) · Current Nutrition & Food Science · doi:10.2174/0115734013315621240802055207 · Cited by 10
Miao, J., Gao, L., Liu, X., Cai, W., Chen, L., Chen, M., & Sun, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1455964 · Cited by 8
Systematic Review: Impact of Bisphenol-A (BPA) Exposure on Human Health
Sulistiyani, S., Triswindyaningrum, O. I., & Darundiati, Y. H. (2025) · JURNAL KESEHATAN LINGKUNGAN · doi:10.20473/jkl.v17i1.2025.85-98 · Cited by 10
Gałczyńska, D., Daniluk, J., Buczek-Kutermak, A., Pruś, P., & Pluta, D. (2025) · Biomedicines · doi:10.3390/biomedicines13061341 · Cited by 8
Fernández-Macías, J. C., Ochoa‐Martínez, Á. C., Pérez-López, A. A., Pérez-López, A. L., Neri-Maldonado, I., Piña-López, I. G., & Pérez‐Maldonado, I. N. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-19245-4 · Cited by 8
Günday, Ö. K., Erdoğan, M. Ö., Pehlivan, A., & Yılmazer, M. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02577-y · Cited by 12
Fu, L., Li, Y., Bian, Y., Wang, Q., Li, J., Wang, Y., Zhang, T., Zou, X., Cui, L., & Chen, Z. (2023) · Reproductive Sciences · doi:10.1007/s43032-022-01131-6 · Cited by 8
Shirvanizadeh, F., Eidi, A., Hafezi, M., & Eftekhari‐Yazdi, P. (2023) · JBRA · doi:10.5935/1518-0557.20230065 · Cited by 16
Nandakumar, M., Das, P., Sathyapalan, T., Butler, A. E., & Atkin, S. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126330 · Cited by 12
Wang, J., Teng, F., Wu, Q., Wu, Y., & Hu, L. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-3031 · Cited by 8
Unraveling PCOS: Exploring its causes and diagnostic challenges
Dar, M. A., Maqbool, M., Qadrie, Z., Ara, I., & Qadir, A. (2024) · Open Health · doi:10.1515/ohe-2023-0026 · Cited by 7
Peng, H., Ren, J., Zhao, Y., Fang, X., Wang, X., Liu, C., & Wan, Z. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112235 · Cited by 7
Al‐Harbi, L. N., AlSedairy, S. A., Alshammari, G. M., Binobead, M. A., & Arzoo, S. (2025) · Pharmaceuticals · doi:10.3390/ph18091291 · Cited by 7
Vascular imbalance in polycystic ovary syndrome: Insights into endothelial dysfunction
Kıran, T. R., Erdem, M., Yildirim, E. O., & İnceoğlu, F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332030 · Cited by 7
Berkel, Ç. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70161 · Cited by 7
Xin, X., Dong, L., Li, J., Zhang, J., & Wu, H. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2565437 · Cited by 8
Tempol modulates lncRNA-miRNA-mRNA ceRNA networks in ovaries of DHEA induced PCOS rats
Li, T., Zhang, T., Gao, H., Wang, H., Yan, H., Wan, Z., Liu, R., & Yin, C. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106175 · Cited by 7
Yan, N., Song, J., Jie, H., Lee, P., Liu, S., & Yuan, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1310122 · Cited by 7
Pesonen, E., Farrahi, V., Brakenridge, C. J., Ollila, M., Morin-Papunen, L. C., Nurkkala, M., Jämsä, T. J., Korpelainen, R., Moran, L., Piltonen, T., et al. (2024) · Human Reproduction · doi:10.1093/humrep/deae232 · Cited by 8
Association of uric acid and fructose levels in polycystic ovary syndrome
Feng, D., Wang, X., Song, J., Yang, H., Peng, Y., Wang, X., Chen, W., Li, P., Fang, Y., Shi, B., et al. (2024) · Human Reproduction · doi:10.1093/humrep/deae219 · Cited by 7
Gökçek, İ., Uyanık, G., Tutar, T., & Gözer, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03588-5 · Cited by 8
He, Y., Wang, Y., Wang, X., Deng, S., Wang, D., Huang, Q., & Lyu, G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431200 · Cited by 7
Kwiatkowski, J., Akpang, N., Zaborowska, Ł., & Ludwin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157525 · Cited by 10
PCOS Perception analysis prediction using Machine learning algorithms
Sakthipriya, D., Thangavel, C., Shivayavashilaxmipriya, S., & Harinee, V. S. (2022) · IEEE International Conference on Recent Advances and Innovations in Engineering (ICRAIE) · doi:10.1109/icraie56454.2022.10054279 · Cited by 7
Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
Alsaffar, S. F., & Alsaffar, S. F. (2023) · Egyptian journal of Immunology · doi:10.55133/eji.300405 · Cited by 9
An overview of the physiopathology and various treatment strategies for polycystic ovary syndrome
Rajabi, A., Babaie, S., Oskouei, B. S., Mehdizadeh, A., & Farshbaf‐Khalili, A. (2023) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000088 · Cited by 7
Evaluation of CRP/Albumin Ratio in Polycystic Ovarian Syndrome
Upadhyay, N., Almeida, E. A., Singh, A., Madhu, S. V., Puri, D., & Mehndiratta, M. (2023) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-023-01897-y · Cited by 8
Coşar, A., Özcan, P., Tanoğlu, F. B., Tok, O. E., Özkara, G., Timur, H. T., Çetin, Ç., & Neccar, D. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2302086 · Cited by 9
The adipokines progranulin and omentin – novel regulators of basic ovarian cell functions
Sirotkin, A. V., Fabová, Z., Loncová, B., Bauerová, M., & Harrath, A. H. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01215-9 · Cited by 7
Liu, X., Wang, Y., Wang, Y., Bai, Y., Kang, A., Cai, Q., Liu, H., Zhang, M., Xu, C., & Zhang, F. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf082 · Cited by 6
Patwari, P., Batra, N., Sen, K., Saha, A., Kumari, B., Basu, M., Mitra, S., Das, K., Kamilya, G., Baidya, A., et al. (2025) · Clinical Endocrinology · doi:10.1111/cen.15302 · Cited by 7
Ye, J., Wang, S., Wang, Z., Jiang, Y., Jia, J., Yang, Y., Huo, L., Liu, X., Zhou, Y., Yang, Z., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s532920 · Cited by 7
Ding, Z., Liao, K., Liang, K., Zhang, S., Pei, Z., Zhang, F., Zhou, L., & Xu, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1629837 · Cited by 6
PCOS phenotypes and hematological immune-inflammatory indices: A comparative evaluation
Kından, A., Kından, G., Soysal, Ç., & Turan, V. (2025) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2025.104823 · Cited by 6
Polycystic Ovarian Syndrome and the Long-Term Risk of Arrhythmias
Reinert, M. S., Ryde, H. V., Sørensen, L. M., Johansen, S. E., Svendsen, P. F., Køber, L., Fosbøl, E. L., & Havers‐Borgersen, E. (2026) · Circulation · doi:10.1161/circulationaha.125.078039 · Cited by 6
Cardiovascular Dysfunction in Polycystic Ovary Syndrome: Mitochondrial and Inflammatory Mechanisms
Badejogbin, O. C., Agunloye, M. O., Chijioke‐Agu, O. E., Olubiyi, M. V., Olugbuyiro, S. O., Soetan, O. A., Bamgbose, O. A., & Olaleye, T. O. (2026) · BioMed Research International · doi:10.1155/bmri/1110229 · Cited by 8
Dietary Factors and the Risk of Depression among Women with Polycystic Ovary Syndrome
Łagowska, K., Bajerska, J., & Pieczyńska-Zając, J. M. (2024) · Nutrients · doi:10.3390/nu16060763 · Cited by 7
Zhao, J., Li, X., & Chen, Q. (2024) · Gene · doi:10.1016/j.gene.2024.148504 · Cited by 6
Yu, X., Liu, S., Wan, S., Chen, Q., Song, Y., Feng, G., Zhang, X., Bai, L., & Zhu, Y. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112274 · Cited by 7
Chen, H., Li, T., Gao, R., Cheng, M., Zhang, Q., Liu, X., Chen, M., Liao, X., & Qin, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1379293 · Cited by 7
Polycystic ovary syndrome and miscarriage: a narrative review
Bui, L. M., Aghajanova, L., Lathi, R. B., & Sokalska, A. (2024) · F&S Reviews · doi:10.1016/j.xfnr.2024.100078 · Cited by 6
Mesenchymal Stromal Cell Exosome-Induced Vascular Regeneration in a PCOS Mouse Model
Teng, X., Wang, X., & Wang, Z. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01720-7 · Cited by 6
Alesi, S., Teede, H. J., Moran, L., Enticott, J., Silva, K. D., & Mousa, A. (2024) · Biomolecules · doi:10.3390/biom14121544 · Cited by 6
Wang, L., Zhang, Y., Ji, F., Si, Z., Liu, C., Wu, X., Wang, C., & Chang, H. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70014 · Cited by 6
Chen, L., Hui, L., Shi, Y., Wang, A., Zhang, Y., Yao, X., & Li, J. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112639 · Cited by 6
Gut feelings–the gut microbiome as a regulator of mental health in polycystic ovary syndrome
Arffman, R. K., Folch, B. A., Leonés-Baños, I., & Altmäe, S. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.09.014 · Cited by 7
Gülücü, S., & İlkin Seda, C. A. N. (2022) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20220854 · Cited by 6
Strategies and Challenges of Mesenchymal Stem Cells-Derived Extracellular Vesicles in Infertility
Li, Y., Wei, S., Li, S., & Zheng, P. (2024) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2023.0094 · Cited by 8
Dadkhah, M., Gholizadeh, N., Azgomi, R. N. D., Hosseinzadeh, S., Hamedeyazdan, S., Haghighat, K., Afshari, S., Salimi, M., & Jazani, A. M. (2024) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-143290 · Cited by 7
Zheng, M., & Zhao, F. (2024) · Immunologic Research · doi:10.1007/s12026-024-09487-4 · Cited by 6
Unveiling the influences of prenatal and maternal factors on the journey of an autistic child
Abdelkader, A., Alradini, F. A., Alosaimi, A. A., Abbas, A., Judeh, Z., Esaid, T. E. A., Saleh, A., Shah, J., & Amer, S. A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1467821 · Cited by 9
Li, Q., Liu, L., Liu, Y., Zheng, T., Chen, N., Du, P., & Ye, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1493771 · Cited by 8
SRC involves in lysosomal function and regulates ferroptosis in polycystic ovary syndrome
Wang, T., Chen, X., & Li, C. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01637-y · Cited by 6
Kwiatkowski, J., Akpang, N., Ziemkiewicz, Z., Zaborowska, Ł., & Ludwin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178192 · Cited by 7
Wang, M., Diao, K., Richard, M., Dai, L., Hu, T., & Ding, H. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.105548 · Cited by 6
Polycystic ovary syndrome and cardiovascular risk: asking the right questions
Safwan, N., Saadedine, M., Merz, C. N. B., & SHUFELT, C. L. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae159 · Cited by 6
Clarke, S., Jangid, G., Nasr, S., Atchade, A., Moody, B. L., & Narayan, G. (2023) · Cureus · doi:10.7759/cureus.45354 · Cited by 5
“Patients with PCOS are also at risk of developing type 2 diabetes mellitus as a result of insulin resistance and adipose retention, which carries additional health risks [3].”
BackgroundAkintola, T. E., Akintunde, J. K., Eteng, O. E., Thomas, F. C., & Adeleke, J. T. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100202 · Cited by 7
IL-33 and soluble ST2 in follicular fluid are associated with premature ovarian insufficiency
Tang, M., Sun, X., Li, P., Deng, W., Zhan, X., Sun, P., & Shi, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1463371 · Cited by 6
Limsrivilai, J., Lai, A. Y.-H., Li, S. T. H., Abdullah, M., Ali, R. A. R., Aniwan, S., Bui, H. H., Chou, J., Hilmi, I. N., Lim, W. C., et al. (2025) · Intestinal Research · doi:10.5217/ir.2024.00085 · Cited by 10
Awate, S. A., & Kaur, G. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177749 · Cited by 5
Du, M., & Ge, H. (2025) · Medicine · doi:10.1097/md.0000000000042481 · Cited by 5
Zheng, B., Che, X., Chen, Z., Cheng, D., Huang, C., Zeng, Z., & Mo, Z. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70116 · Cited by 5
Zaki, A. K. A., Alharbi, N. S., Almundarij, T. I., & Albarrak, S. M. (2025) · Veterinární Medicína · doi:10.17221/116/2024-vetmed · Cited by 5
Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights
Li, C.-J., Lin, L., Lin, P.-H., Chen, Y.-C., Lin, P.-W., Wen, Z., & Tsui, K. (2025) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001281 · Cited by 6
Berkel, Ç. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115425 · Cited by 5
Li, Y., Liu, Z., Tan, Y., Chen, Y., Huang, Z., & Chen, Y. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01779-z · Cited by 7
Xu, H., Liu, X., Sun, W. Y., Dong, X., Liu, X., Xie, Y., He, J., Ali, A. M. M., Chen, M., Wu, L., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1709581 · Cited by 6
Luteolin alleviates PCOS by inhibiting AR/STAT3/NLRP3-mediated granulosa cell pyroptosis
Ouyang, X., Tang, H., Yang, Y., Hao, X., Jiang, X., Zhou, Q., & Li, L. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-025-01952-4 · Cited by 5
Wang, W., Hao, J. C., & Shi, Y. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2123914 · Cited by 5
Metadata
- Authors
- Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B.
- Affiliations
- Medical University of Warsaw (PL)
- Warsaw University of Life Sciences (PL)
- Department of Gynaecological Endocrinology, Poznan University of Medical Sciences, 60-535 Poznan, Poland
- Corresponding author
- Rudnicka, Ewa
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-06
- Volume
- 22
- Issue
- 7
- Pages
- 3789
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8038770
- OpenAlex
- W3145310045
- Cited by
- 680
- References
- 99
- Citations by year
- 2026: 152 · 2025: 172 · 2024: 165 · 2023: 112 · 2022: 74 · 2021: 5
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, low-grade inflammation, inflammatory cytokines, C-reactive protein, advanced glycation end products, RAGE, hyperinsulinemia, obesity, endothelial dysfunction, oxidative stress, cardiovascular risk, pregnancy complications, hyperandrogenism, insulin resistance
- MeSH terms
- Aging, C-Reactive Protein, Chronic Disease, Diabetes Mellitus, Type 2, Female, Humans, Inflammation, Obesity, Polycystic Ovary Syndrome, Cytokines, Metabolic Syndrome, Endothelial Cells, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.